Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06384651 · ClinicalTrials.gov registry record · Phase 4

Intraosseous vs. Intravenous Vancomycin Administration in Total Ankle Arthroplasty

A Phase 4 study of Infections and Ankle Arthritis, sponsored by The Methodist Hospital Research Institute.

Recruiting
Registry status
Phase 4
Development phase
40
Enrollment target
1
Study location

NCT06384651: Recruiting Phase 4 study of Infections and Ankle Arthritis, sponsored by The Methodist Hospital Research Institute.

NCT06384651 is a Phase 4 study of Infections and Ankle Arthritis that is actively recruiting participants, run by The Methodist Hospital Research Institute. The registered enrollment target is 40 participants, below the 3,406-participant average among 26 other Infections trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06384651, a Phase 4 study of Infections and Ankle Arthritis, is actively recruiting participants, sponsored by The Methodist Hospital Research Institute.

RECRUITING
Registry status
Phase 4
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to compare two different antibiotic regimens and techniques during total ankle arthroplasty (TAA). Primary Objective: Comparable levels of vancomycin will be found in bone, soft tissue, and systemic samples between patient groups. Secondary Objective: Compare 30 day and 90 day post-operative complication rates (infection) between the control (standard IV administration of vancomycin) vs the interventional group (intraosseous administration of vancomycin). The investigators hypothesize that there will be no difference in complication (infection) rates between groups.

Interventions

  • DRUG Intraosseous Vancomycin Injection
  • DRUG Intravenous Vancomycin

Study Locations (1)

Texas

  • Houston Methodist Hospital - Houston

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2024-12-03
Est. Completion 2027-12
Phase Phase 4

What NCT06384651 shows while recruiting

NCT06384651 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 3,406-participant average among 26 other Infections trials with a reported enrollment target (99% lower).

The record links to 2 conditions, with Infections appearing as the primary indexed condition, and to 2 interventions - of which Intraosseous Vancomycin Injection is the first listed.

NCT06384651 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT06384651 about?

NCT06384651 is a clinical study titled "Intraosseous vs. Intravenous Vancomycin Administration in Total Ankle Arthroplasty". The purpose of this study is to compare two different antibiotic regimens and techniques during total ankle arthroplasty (TAA). Primary Objective: Comparable levels of vancomycin will be found in bone, soft tissue, and systemic samples between patient groups. Secondary Objective: Compare 30 day an...

What is the current status of trial NCT06384651?

This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 40 participants. The study started on 2024-12-03. Estimated completion is 2027-12.

What conditions does trial NCT06384651 study?

This clinical trial studies the following conditions: Infections, Ankle Arthritis.

What interventions are being tested in trial NCT06384651?

The interventions under investigation include: Intraosseous Vancomycin Injection (DRUG), Intravenous Vancomycin (DRUG).

Who is sponsoring clinical trial NCT06384651?

This trial is sponsored by The Methodist Hospital Research Institute, which has 126 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06384651 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Infections

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06384651's enrollment target sits among peer trials

40 20th of 26 higher than 7 of 26 other Infections trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Infections trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06384651, the US trial registry maintained by the National Library of Medicine. NCT06384651 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.